SAREPTA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
SAREPTA THERAPEUTICS, INC. (SRPT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of 1.50% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2017-02-28
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2016 was 1.50%, a 400.00% increase from fiscal 2015.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2015 was 0.30%, a 87.50% decline from fiscal 2014.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2014 was 2.40%, a 71.43% increase from fiscal 2013.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2013 was 1.40%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month |
|---|---|
| 2016-12-31 | 1.50% 10-K · filed 2017-02-28 |
| 2015-12-31 | 0.30% 10-K · filed 2017-02-28 |
| 2014-12-31 | 2.40% 10-K · filed 2017-02-28 |
| 2013-12-31 | 1.40% 10-K · filed 2016-02-25 |
| 2012-12-31 | -0.60% 10-K · filed 2015-02-26 |
| 2011-12-31 | 54.60% 10-K · filed 2014-03-03 |
| 2010-12-31 | 3.90% 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |